United states telemedicine market 2011-2021 brochure

United States TelemedicineMarket Opportunities , 2011 - 2021

P h a r m a & H e a l t h c a r e C o n s u l t a n t s

2

© Pharmaion

S. No. Contents

1. Product Overview

2. Research Methodology

3. Analyst View

4. Global Telemedicine Market Overview

5. United States Telemedicine Market Overview

6. United States Telemedicine Market Outlook

6.1. Market Size & Forecast

6.1.1. By Value

6.2. Market Share & Forecast

6.2.1. By Type

6.2.2. By Mode of Communication

6.2.3. By End User

6.2.5. By Region

6.2.6. By Organized Vs. Unorganized

7. United States Telemedicine Service Market Outlook


7.1.1. By Value


7.2.1. By Type

7.2.2. By End User

8. United States Telemedicine Technology Market Outlook


8.1.1. By Value

T a b l e o f C o n t e n t s

3

© Pharmaion

S. No. Contents


8.2.1. By Type

8.2.2. By End-User

9. Market Dynamics

9.1. Drivers

9.2. Challenges

10. Market Trends & Developments

10.1. Push To Talk (PTT) Technology

10.2. Technological Upgradations Spurring Home Healthcare Solutions

10.3. Adoption of Tele-Wound Care

10.4. Pervasive Video

10.5. Technological Innovations

11. SWOT Analysis

12. Value Chain Analysis

13. Policy & Regulatory Landscape

14. United States Economic Profile

15. Competitive Landscape

15.1. Honeywell Life Care Solutions

15.2. Allscripts Healthcare Solutions, Inc.

15.3. 3M Health Information System

15.4. Cisco Systems, Inc.

15.5. Polycom, Inc.

15.6. AT&T, Inc.


4

© Pharmaion

S. No. Contents

15.7. Teladoc, Inc.

15.8. MDLIVE Inc.

15.9. AMD Global Telemedicine, Inc.

15.10. InTouch Technologies, Inc.

16. Strategic Recommendations

17. About Us & Disclaimer


5

© Pharmaion

P r o d u c t O v e r v i e w

Telemedicine

• Telemedicine is the use of telecommunication to exchange medical

information and provide healthcare services from one distant

location to another.

• Clinical services are delivered through internet by using video

conferencing, smart phones, e-mail, and other telecommunication

medias.

• Telemedicine is considered as a safe and worthwhile way to deliver

clinical information and healthcare services. It helps in eliminating

distance barriers, and also increases the access to medical services

for patients, especially those who are located in remote areas.

• By implementing telemedicine, the travel time of healthcare experts

and nurses can be avoided, and also the patients can save money

by avoiding hospitalization. Therefore, quality treatment is provided

at reduced cost.

• Following are the two end users of telemedicine:

Telehospital / Teleclinic: Uses telemedicine for inpatients i.e.

patients within the hospital

Telehome: Uses telemedicine for outpatients i.e. patients

outside the hospital

6

© Pharmaion

R e s e a r c h M e t h o d o l o g y

Primary Research

•Identifying Key Opinion Leaders

•Questionnaire Design

•In-depth Interviews

•Coverage across Value Chain market

Market Estimation & Forecasting

Bottom-Up or Top-down approach for Market size estimation

Historical trend examination

Impact analysis of drivers and challenges to market growth

Statistical evaluation to develop the actual forecast

Data Validation, Analysis and Interpretation

Data validation through Primary & Secondary outreach, data analysis and interpretation of key findings

Preliminary Data Mining

Qualitative and Quantitative research

2016E 2017F 2018F 2019F 2020F 2021F

CAGR (2016E-2021F): XX%

US Telemedicine Market Opportunities, 2011 - 2021

Secondary Research

•Government websites

•Company annual reports

•White papers

•Investor presentation

•Financial reports

7

© Pharmaion


Baseline Methodology:

For the study of the United States telemedicine market, Pharmaion has gathered information through an

exhaustive search of credible databases prudently evaluated all the collected information and presented it in

the most accurate and detailed manner.

Primary Sources

Key Stakeholders:

Product/Brand Managers

Business Development

Managers

Regional Mangers

Regulatory Affairs Personnel

Marketing & Sales Managers

Head of Patient Support

Programme

Substantial data points for analysis, interpretation and market size estimation

Data Triangulation

(Data validation

through cross verification

from primary & secondary

sources)

Qualitative and quantitative data from company

website, financial reports, research articles, designed

questionnaires etc.

In-depth interviews of key stakeholders of

major companies

Secondary Sources

Analysis of Data from credible sources: Centres for Disease

Control and Prevention (CDC)

Association of American Medical Colleges (AAMC)

American Telemedicine Association (ATA)

8

© Pharmaion


United States Telemedicine Market - Market Size Estimation

United States Telemedicine market has been segmented into two categories, namely, Service andTechnology.

Service segment has been further categorized into sub-segments - Monitoring, Consultation,Diagnosis, Treatment and Others.

While, Technology segment has been classified into sub-segments - Hardware, Software and Network& Telecom.

Calculation of United States Telemedicine

Market Size

To

p-d

ow

n A

pp

ro

ach

Calculation of Segment

Market Size

Sub-Segment Market Size Calculation

Sub-Segment Market Share (From

Primary and Secondary

Research) * Segment Market

Size

Calculation of Sub-segment market size

9

© Pharmaion

I n d u s t r y B r i e f

US Telemedicine Market to Cross $ 13 billion by 2021

Increasing healthcare costs and growing incidence rate of chronic diseases coupled with growing technologicaladvancements to drive United States telemedicine market

According to Pharmaion report, “United States Telemedicine Market Opportunities, 2011 - 2021”, thetelemedicine market in the United States is projected to cross $ 13 billion by 2021. Growth in the market isanticipated on account of increasing healthcare costs, growing aging population, and rising incidence of chronicdiseases. Moreover, various reforms in the healthcare industry such as Patient Protection and Affordable CareAct (PPACA), growing technological advancements and increasing awareness among citizens regarding healthmanagement and cost effective patient monitoring are driving telemedicine services and technologies market inthe United States.

United States telemedicine market has been segmented into two categories – service and technology. Servicesegment dominated the United States telemedicine market in 2015, and is anticipated to continue its dominancethrough 2021. However, the telemedicine technology segment is projected to witness higher growth rate, invalue terms, during 2016 - 2021. In 2015, real time mode was the most preferred mode of communication fordelivering telemedicine services, as it is cost-effective and helps in saving time by avoiding unnecessaryemergency visits and hospitalizations.

“Telemedicine is anticipated to improve healthcare outcomes, reduce consumer expenditure and provide easyinteraction between healthcare service providers and patients. During the forecast period, with growingtechnological advancements, telemedicine will become more user-friendly, thereby aiding overall market growthin the United States. Moreover, growing adoption of technologies like Push-to-Talk (PTT), Tele-Wound Care andPervasive Video is further anticipated to boost the country’s telemedicine market over the next five years.” saidMs. Pritpal Kaur, Consultant with Pharmaion Consultants, a research based global management consulting firmfocused on pharma and healthcare industry.

http://www.pharmaion.com/report/united-states-telemedicine-market-opportunities-2011--2021/50.html

10

© Pharmaion

S a m p l e D a t a - S n a p s h o t

10 20 30 40 50 60 70 80 90 100 110

2011 2012 2013 2014 2015 2016E2017F2018F2019F2020F2021F

United States Telemedicine Market Size, By Value, 2011-2021F (USD Billion)

United States Telemedicine Market Share, By Type, By Value, 2011-2021F

30% 31% 32% 33% 34% 35% 36% 37% 38% 39% 40%

70% 69% 68% 67% 66% 65% 64% 63% 62% 61% 60%

2011 2012 2013 2014 2015 2016E2017F2018F2019F2020F2021F

Service

Technology

United States Telehospital / Teleclinic Market Share, By Specialty, By Value, 2011-2021F

23% 24% 25% 26% 27% 28% 29% 30% 31% 32% 33%

3% 3% 3% 3% 3% 3% 2% 2% 2% 2% 2%9% 9% 9% 9% 9% 9% 8% 8% 8% 8% 8%10% 10% 10% 11% 11% 11% 11% 11% 12% 12% 12%

21% 22% 23% 24% 25% 26% 27% 28% 29% 30% 31%

34% 33% 32% 31% 30% 29% 28% 27% 26% 25% 24%

2011 2012 2013 2014 2015 2016E 2017F 2018F 2019F 2020F 2021F

Teleradiology

Telecardiology

Telepsychology

Teledermatology

Telepathology

Others*

10 20 30 40 50

2011 2012 2013 2014 2015

North-East Region

1020

3040

50

2011 2012 2013 2014 2015

West Region

10 20 30 40 50

2011 2012 2013 2014 2015

Mid-West Region

10 20 30 40 50

20112012201320142015

South Region

United States Telemedicine Market Size, By Region, By Value, 2011-2015 (USD Billion)

United States Telemedicine Service Market Share, By End User, By Value, 2011-2021F

18% 19% 20% 21% 22% 23% 24% 25% 26% 27% 28%

82% 81% 80% 79% 78% 77% 76% 75% 74% 73% 72% Telehospital /TeleclinicTelehome

United States Telemedicine Service Market Size, By Value, 2011-2021F (USD Billion)

10 20 30 40 50 60 70 80 90 100 110

2011 2012 2013 2014 2015 2016E2017F2018F2019F2020F2021F

Allscripts Healthcare Solutions, Inc. (NYSE: MDRX)

OWNERSHIP STRUCTURE

(2014)Institutional

Holdings, 100.00%

Wellington Mangement Group LLP, 17.00%

Iridian Asset Management LLC/CT, …

Blue Harbour …Vanguard Group …

Glenhill Advisors LLC, …

Others, 17.00%

R e p o r t O r d e r i n g

To View Sample OR Purchase Report

Report Price

Report Name: United States Telemedicine Market Opportunities,

2011 - 2021

License Type Price

Single User License $2500

Single User License Print $3000

Enterprise License $5000

11



12

© Pharmaion

A b o u t U s & D i s c l a i m e r

NORTH AMERICA

Pharmaion Consultants LLC

708 3RD Avenue, 6th Floor, New York, NY,

United State, 10017

[email protected]

+1 646 862 0089

www.pharmaion.com

About Us :

Pharmaion is a research based management consulting firm focused exclusively on Healthcare & Pharmaceutical industry.

Pharmaion’s core values are value, integrity and insight. Led by a team of dynamic industry experts, Pharmaion provides itscustomers with high value market research and advisory services that helps them identify new market opportunities, growthengines and innovative ways to capture the market share. As a result, Pharmaion’s clients lead rather than follow markettrends. Not bound by legacy, Pharmaion’s cutting-edge research model leverages its decades of research knowledge and anincreased use of technology as engines of innovation to deliver unique research value. Provided as an alternative to traditionalmarket research, Pharmaion’s reports do not just deliver data and knowledge rather highlights the insights in a more usable andinteractive format for its clients.

Pharmaion is committed to assisting customers worldwide with their unique market research needs by providing them withcomprehensive, value-added solutions and professional market intelligence services. Pharmaion employs the industry’s best-trained industry Analysts and Consultants, which advises and assists customers in meeting their full service market researchand consulting requirements.

Related Reports

India Stem Cell Market Forecast & Opportunities, 2020

India Infertility Treatment Market Forecast & Opportunities, 2020

Global Tissue Engineered Medical Device Market Forecast & Opportunities, 2020

Disclaimer :The contents of this report are based on information generally available to the public from sources believed to be reliable. No representation ismade that it is timely, accurate or complete. Pharmaion Consultants has taken due care and caution in compilation of data as this has beenobtained from various sources including which it considers reliable and first hand. However, Pharmaion Consultants does not guarantee theaccuracy, adequacy or completeness of any information and it is not responsible for any errors or omissions or for the results obtained from theuse of such information and especially states that it has no financial liability whatsoever to the subscribers / users of this report. Theinformation herein, together with all estimates and forecasts, can change without notice. All the figures provided in this document are indicativeof relative market size and are strictly for client’s internal consumption. Usage of the same for purpose other than internal will require priorapproval of Pharmaion Consultants.

ASIA-PACIFIC

Pharmaion Consultants Pvt. Ltd.

A – 51, Sector 57, Noida, National Capital Region,

India - 201301

[email protected]

+91 - 120 - 452 3900

www.pharmaion.com